Please call 1-800-766-7000 to place your order or try our site again later.
R&D Systems Recombinant Human LINGO-1 Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9737LG050
DescriptionThe Recombinant Human LINGO-1 Protein is derived from HEK293. The Recombinant Human LINGO-1 Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS with Trehalose.|
|>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|<0.10 EU per 1μg of the protein by the LAL method.|
|FLJ14594, LERN1, LERN1UNQ201, leucine rich repeat and Ig domain containing 1, leucine rich repeat neuronal 6A, Leucine-rich repeat and immunoglobilin domain-containing protein 1, Leucine-rich repeat neuronal protein 1, Leucine-rich repeat neuronal protein 6A, LINGO1, LRRN6A, LRRN6Aleucine-rich repeat neuronal 6A, MGC17422|
|12 months from date of receipt, ≤ -20° C as supplied. 2 weeks, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution.|
|Reconstitute at 1 mg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok